MicroRNA (
miRNA) deregulation is associated with various
cancers. Among an expanding list of
cancer-related
miRNAs, deregulation of miR-125b has been well documented in many
cancers including breast. Based on current knowledge, miR-125b is considered to be a
tumor suppressor in breast
cancers. While important
messenger RNA (
mRNA) targets have been defined for miR-125b, here, we aimed to further investigate direct/indirect consequences of miR-125b expression in
breast cancer cells by using a transcriptome approach. Upon miR-125b expression, a total of 138
cancer-related genes were found to be differentially expressed in
breast cancer cells. While only a few of these were predicted to be direct
mRNA targets, majority of the gene expression changes were potentially downstream and indirect effects of miR-125b expression. Among these, activated leukocyte
antigen molecule (
ALCAM)
mRNA and
protein levels were found to be highly significantly increased upon miR-125b expression. Given the
tumor suppressor role of miR-125b in our model system, upon silencing of
ALCAM expression, cell proliferation rate re-increased in miR-125b-expressing cells. While
ALCAM's possible context-dependent roles are not clear in
breast cancer, a diverse expression pattern of
ALCAM mRNA was detected in a panel of
breast cancer patient samples. Differentially expressed/regulated
cancer-related genes upon miR-125b expression along with the significant increase of
ALCAM are of future interest to understand how deregulated expression of miR-125b may have a
tumor suppressor role in breast and other
cancers.